本页面由Tiger Trade Technology Pte. Ltd.提供服务

Supernus Pharmaceuticals

42.67
+0.53001.26%
盘后:42.670.00000.00%16:24 EDT
成交量:57.91万
成交额:2,479.02万
市值:24.77亿
市盈率:-22.29
高:43.14
开:42.18
低:42.15
收:42.14
52周最高:59.68
52周最低:40.51
股本:5,803.97万
流通股本:5,166.51万
量比:0.72
换手率:1.12%
股息:- -
股息率:- -
每股收益(TTM):-1.9145
每股收益(LYR):-0.6829
净资产收益率:-10.49%
总资产收益率:0.39%
市净率:2.40
市盈率(LYR):-62.48

数据加载中...

2026/10/06

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/08/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/08/03

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

重要事件披露

Form 8-K - Current report
2026/08/03

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/07/22

重要事件披露

Form 8-K - Current report
2026/06/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/18

重要事件披露

Form 8-K - Current report
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors